Edition:
India

Heekyong Yang

Samsung Electronics flags second-quarter profit jump on solid chip demand, one-off gains from Apple

07 Jul 2020

SEOUL Samsung Electronics Co Ltd flagged a 23% rise in second-quarter operating profit on Tuesday, beating analysts' estimates on solid chip sales to data centres catering for a work-from-home economy during the novel coronavirus pandemic. | Video

Samsung's second-quarter chip sales unlikely made up for smartphone weakness

06 Jul 2020

SEOUL At Samsung Electronics Co Ltd, demand for its chips from data centres bulking up to meet a surge in work-from-home traffic was not likely enough to offset muted sales of its smartphones in the second quarter, analysts said.

UPDATE 2-S.Korea's Hankook Tech chairman sells entire stake to younger son; shares rally

30 Jun 2020

* Chairman Cho Yang-rai sells his 23.59% stake to Cho Hyun-bum

Samsung group heir should not be indicted, South Korea panel recommends

26 Jun 2020

SEOUL An external review panel in South Korea recommended that prosecutors should not indict Samsung Group heir Jay Y. Lee over a 2015 merger and alleged accounting fraud, the Supreme Prosecutors' Office said on Friday.

North Korea warns of retaliatory actions over defectors in South

15 Jun 2020

SEOUL The sister of North Korea's leader has warned of retaliatory measures against South Korea that could involve the military, in the latest escalation of tensions over defectors from the North who have been sending back propaganda and food. | Video

South Korean court denies arrest warrant request for Samsung heir

09 Jun 2020

SEOUL A South Korean court on Tuesday denied an arrest warrant request for Samsung Group heir Jay Y. Lee after prosecutors accused him of accounting fraud and stock manipulation. | Video

Samsung leader appears in court, waits to hear if he'll be jailed again

08 Jun 2020

SEOUL Samsung Group's leader, Jay Y. Lee, appeared before a South Korean court on Monday, awaiting a ruling on whether new allegations including accounting fraud and stock manipulation will send him back to jail after more than two years of freedom.

South Korea's Celltrion aims to start in-human COVID-19 drug trial in July

01 Jun 2020

SEOUL South Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it aims to start in-human clinical trials in late July.

World News